Kursprognose für Ultragenyx Pharmaceutical Inc (RARE)RAREUltragenyx Pharmaceutical Inc

Alphio's RARE stock price prediction model matches the current Ultragenyx Pharmaceutical Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $14.71 (+1.20%). The 1-week path is $14.39 (-1.01%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Ultragenyx Pharmaceutical Inc (RARE) is currently trading at $14.54, with a significant upside potential as analysts have raised price targets to as high as $39, suggesting a potential upside of 166% from current levels. However, the stock has a low RSI of 37.885, indicating it may be oversold, and it has experienced a substantial year-to-date decline of 38.39%. The recent sale of a Priority Review Voucher for $210 million is a positive catalyst, providing non-dilutive capital to support its drug development pipeline. The main risk remains its negative net income, which was -92 million in the latest quarter, indicating ongoing financial challenges. Therefore, while there are positive indicators, the stock's volatility and recent performance suggest a cautious approach, making it a hold for now.

Ultragenyx Pharmaceutical Inc (RARE) last closed at $14.54, losing -4.15%. These facts feed the 1-day and 1-week RARE price prediction above.